Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure

Publication date: September–October 2020Source: Reumatología Clínica (English Edition), Volume 16, Issue 5, Part 1Author(s): Francisco J. Blanco, Esteban Rubio-Romero, Raimon Sanmartí, César Díaz-Torné, Pablo Talavera, Jochen Dunkel, Esperanza Naredo, on behalf of the SONAR Study Team
Source: Reumatologia Clinica - Category: Rheumatology Source Type: research